Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme

被引:20
|
作者
Masuyer, Geoffrey [1 ]
Douglas, Ross G. [2 ,3 ]
Sturrock, Edward D. [2 ,3 ]
Acharya, K. Ravi [1 ]
机构
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[2] Univ Cape Town, Dept Integrat Biomed Sci, ZA-7935 Observatory, South Africa
[3] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa
来源
SCIENTIFIC REPORTS | 2015年 / 5卷
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
ASPARTYL-LYSYL-PROLINE; TERMINAL CATALYTIC DOMAIN; 2; ACTIVE-SITES; N-DOMAIN; CRYSTAL-STRUCTURE; KININASE-II; INHIBITOR; PEPTIDE; FIBROSIS; SPECIFICITY;
D O I
10.1038/srep13742
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Angiotensin-I converting enzyme (ACE) is a zinc dipeptidylcarboxypeptidase with two active domains and plays a key role in the regulation of blood pressure and electrolyte homeostasis, making it the principal target in the treatment of cardiovascular disease. More recently, the tetrapetide N-acetylSer- Asp-Lys-Pro (Ac-SDKP) has emerged as a potent antifibrotic agent and negative regulator of haematopoietic stem cell differentiation which is processed exclusively by ACE. Here we provide a detailed biochemical and structural basis for the domain preference of Ac-SDKP. The high resolution crystal structures of N-domain ACE in complex with the dipeptide products of Ac-SDKP cleavage were obtained and offered a template to model the mechanism of substrate recognition of the enzyme. A comprehensive kinetic study of Ac-SDKP and domain co-operation was performed and indicated domain interactions affecting processing of the tetrapeptide substrate. Our results further illustrate the molecular basis for N-domain selectivity and should help design novel ACE inhibitors and Ac-SDKP analogues that could be used in the treatment of fibrosis disorders.
引用
收藏
页数:12
相关论文
共 50 条